Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Ubiquitin Proteasome Pathway

The ubiquitin-proteasome pathway (UPP) is the primary cytosolic proteolytic machinery for the selective degradation of various forms of damaged proteins. Proteins tagged by ubiquitination (e.g., attachment of ubiquitin to the target molecule) are degraded in the proteasome, a complex intracellular structure composed of multiple enzymatic complexes, presiding over protein catabolism. The end products of its activity are, in fact, small peptides suitable for antigen presentation or amino acid residues that can be recycled within the cell.
The ubiquitin-proteasome system (UPS) has been increasingly recognized as a major system involved in several biological processes such as cell proliferation, adaptation to stress and cell death. The critical role that the Ubiquitin Proteasome Pathway (UPP) plays in cellular signaling coupled with increasing validation of the therapeutic potential of targets in this pathway is accelerating interest in this field among both academic and pharmaceutical researchers.
BioVision is pleased to offer a variety of reagents to the researchers doing research in the Ubiquitin Proteasome Pathway.


Ubiquitin Proteasome Pathway Products

4 Item(s)

per page

4 Item(s)

per page

$
Subscribe to our Newsletter!!
and automatically get enrolled into a raffle to win Google Home.
Offer valid for US customers only.